Alvotech enters into commercialization agreement with
Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area,
Globe Newswire6-02-2023, 16:08
National Automotive Supplier Providing Child Care Benefits 8-02-2023, 00:06